452. RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical Trial

Emily J Culme-Seymour, Chris Mason, Jeff Round et al.|Molecular Therapy|2016

Cited by 0